Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Checking on the Oxbryta launch amid continued COVID-19 uncertainty

Ticker(s): GBT

Who's the expert?

Physician specializing in treating sickle cell patients that treats many sickle cell patients and has at least six months experience treating patients with Oxbryta and has prescribed to date Oxbryta to at least 20 patients

Interview Goal

Understand Physicians experience with Oxbryta for sickle cell anemia patients to date and how COVID-19 may be influencing the launch

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here To Join
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here To Join
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.